Meridian Bioscience (VIVO) Reports In-Line Q2 EPS, Beats on Revenues; Boosts FY18 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St futures gain on tech rebound, Middle East peace hopes
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil falls 1% as traders digest escalation in US-Iran strikes
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Meridian Bioscience (VIVO) Declares $0.125 Quarterly Dividend; 3.5% Yield
April 26, 2018 8:51 AM EDTMeridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.125 per share, or $0.5 annualized.
The dividend will be payable on May 17, 2018, to stockholders of record on May 7, 2018, with an ex-dividend date of May 4, 2018.
The annual yield on the dividend is 3.5 percent.
For... More
